Child Categories
Food & Drug Law
-
Eli Y. Adashi & I. Glenn Cohen, The FDA Initiative to Assure Racial and Ethnic Diversity in Clinical Trials, 36 J. Am. Bd. Fam. Med.
-
Alliance for Hippocratic Medicine v. FDA — Dobbs’s Collateral Consequences for Pharmaceutical Regulation
January 25, 2024
Patricia J. Zettler, Eli Y. Adashi & I. Glenn Cohen, Alliance for Hippocratic Medicine v. FDA — Dobbs’s Collateral Consequences for Pharmaceutical Regulation, 388 New…
-
Jacob S. Sherkow, Eli Y. Adashi & I. Glenn Cohen, Assessing—and Extending—California’s Insulin Manufacturing Initiative, JAMA (2023).
-
Integrity of SARS-CoV-2 Laboratory-Developed Tests—Reply
January 25, 2024
Eli Y. Adashi & I. Glenn Cohen, Integrity of SARS-CoV-2 Laboratory-Developed Tests—Reply, 328 JAMA 478 (2022).
-
Capping Prescription Drug Costs: State Initiatives to the Rescue?
January 25, 2024
Eli Y. Adashi & I. Glenn Cohen, Capping Prescription Drug Costs: State Initiatives to the Rescue?, 105 R.I. Med. J. 53 (2022).
-
Winston McCormick, Eli Y. Adashi & I. Glenn Cohen, Expanding the Blood Pool: The Limitations of the FDA’S Current MSM Blood Deferral, 97 Mayo Clinic…
-
Eli Y. Adashi & I. Glenn Cohen, The CMS Vaccine Mandate at the Supreme Court: A Hippocratic Imperative, Am. J. Med. (2022).
-
SARS-CoV-2 Laboratory-Developed Tests
January 25, 2024
Eli Y. Adashi & I. Glenn Cohen, SARS-CoV-2 Laboratory-Developed Tests, JAMA (2022).
-
The next two decades of mifepristone at FDA: History as destiny
January 25, 2024
Eli Y. Adashi et al., The next two decades of mifepristone at FDA: History as destiny, Contraception (2022).
-
Deadly Legacy-The 510(k) Path toMedical Device Clearance
January 25, 2024
Eli Y. Adashi, Katina M. Robison & I. Glenn Cohen, Deadly Legacy-The 510(k) Path toMedical Device Clearance, 157 JAMA Surgery 185 (2021).
-
Mason Marks & I. Glenn Cohen, Patents on Psychedelics: The Next Legal Battlefront of Drug Development, 135 Harv. L. Rev. F. (2022).
-
Kerry Lynn Macintosh, I. Glenn Cohen, Jacob. S. Sherkow & Eli Y. Adashi, Gene Editing Sperm and Eggs for Use in Clinical Trials – The…
-
Sara Gerke, Timo Minssen & I. Glenn Cohen, Ethical and Legal Challenges of Artificial Intelligence-Driven Health Care, in Artificial Intelligence in Healthcare (Adam Bohr &…
-
Ethical and Legal Issues of Ingestible Electronic Sensors
January 25, 2024
Sara Gerke, Timo Minssen, Helen Yu & I. Glenn Cohen, Ethical and Legal Issues of Ingestible Electronic Sensors, 2 Nature Electronics 329 (2019).
-
I. Glenn Cohen & Nicholas Bagley, Private Rights and the Public Interest in Drug and Medical Device Litigation, 180 JAMA Internal Med. 299 (2019).
-
When Science and Politics Collide: Enhancing the FDA
January 25, 2024
Eli Y. Adashi, Rohit S. Rajan & I. Glenn Cohen, When Science and Politics Collide: Enhancing the FDA, 364 Science 628 (2019).
-
Regulation of Stem Cell Therapy Travel
January 25, 2024
I. Glenn Cohen & Shelly Simana, Regulation of Stem Cell Therapy Travel, 4 Current Stem Cell Rep. 220 (2018).
-
Every Pill You Take
January 25, 2024
I. Glenn Cohen & Alex Pearlman, Every Pill You Take, New Scientist, Sept. 29, 2018, at 22.
-
Craig M. Klugman, Laura B. Dunn, Jack Schwartz & I. Glenn Cohen, Response to Open Peer Commentaries on “The Ethics of Smart Pills and Self-Acting…
-
Influence, Integrity, and the FDA: An Ethical Framework
January 25, 2024
Spencer Phillips Hey, I. Glenn Cohen, Eli Y. Adashi & Aaron S. Kesselheim, Influence, Integrity, and the FDA: An Ethical Framework, 357 Science 876 (2017).
-
Nudging the FDA
January 25, 2024
W. Nicholson Price II & I. Glenn Cohen, Nudging the FDA, 10 Am. Interest 35 (2014).